TNF Pharmaceuticals Plunges 20.97% Amid Earnings Fears

TNF Pharmaceuticals, Inc. (TNFA) experienced a significant drop of 20.97% in pre-market trading on September 1, 2025, sparking concerns among investors and analysts alike.

One of the key factors contributing to the stock's decline is the upcoming earnings report, which is estimated to be released on November 12, 2025. Investors are closely monitoring the company's financial performance, as past earnings reports have had a substantial impact on the stock's valuation.

Additionally, the trading halt announced earlier this year due to pending news has added to the uncertainty surrounding the company. This halt, which occurred in August 2024, was a result of significant news pending, which has left investors on edge and contributed to the recent volatility in the stock price.

Overall, the combination of the upcoming earnings report and the previous trading halt has created a challenging environment for TNF Pharmaceuticals, Inc. As the company navigates these uncertainties, investors will be closely watching for any developments that could impact the stock's performance in the coming months.